Alessia Grozio

Title: Alessia Grozio: Innovator in Medical Treatments

Introduction

Alessia Grozio is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of medical treatments, particularly in the area of age-associated conditions. With a total of 2 patents, her work focuses on innovative methods and compositions that aim to improve health outcomes.

Latest Patents

Grozio's latest patents include compositions and methods of treatment using nicotinamide mononucleotide (NMN). These patents describe various methods and compositions for treating age-associated conditions and other medical issues, such as muscle diseases, type 2 diabetes, and obesity. The patents detail methods for enhancing cellular uptake of NMN and stimulating NAD+ production. They also describe various mammalian cells and cell lines that include a cDNA encoding a Slc12a8 protein. Additionally, gene therapy vectors comprising a nucleic acid encoding Slc12a8 and non-human animals with an inactivating mutation in the Slc12a8 gene are disclosed. Furthermore, methods for screening candidate compounds to identify those that promote NMN transport are also included.

Career Highlights

Alessia Grozio is affiliated with Washington University, where she continues her research and development in medical treatments. Her work has garnered attention for its potential to address significant health challenges faced by many individuals.

Collaborations

Grozio collaborates with Shin-Ichiro Imai, a fellow researcher who shares her passion for advancing medical science. Their partnership enhances the scope and impact of their research efforts.

Conclusion

Alessia Grozio is a trailblazer in the field of medical innovations, with a focus on treatments that address age-related health issues. Her contributions through her patents and collaborations are paving the way for future advancements in medical science.